Tunch Akmandor, Clinical Intern and PhD in Cancer Immunotherapy at Istanbul University-Cerrahpasa, shared a post on LinkedIn:
“Delighted to have been selected as a European Representative for the Global Access Special Interest Focus Group at the Society for Immunotherapy of Cancer (SITC).
I look forward to contributing to discussions surrounding global access, equity, and international collaboration in cancer immunotherapy and oncology care, while engaging with colleagues across the global immuno-oncology community.
Grateful for this opportunity and excited for the collaborations and initiatives ahead.”
Other articles featuring Tunch Akmandor on OncoDaily.
